Clinigen Group plc (‘Clinigen’ or the ‘Group’, AIM:CLIN) the global
specialty pharmaceutical company, today announces that it has received
the first Drug Shortage Assistance Award from the US Food and Drug
Administration (FDA) in recognition of its contribution in
addressing a US shortage of Foscavir® (foscarnet sodium) injection.
for Clinigen Group plc Receives FDA’s First Ever Drug Shortage Assistance Award investment picks